Rictor/mTORC2 facilitates central regulation of energy and glucose homeostasis

Molecular Metabolism

Volumn 3, Issue 4, 2014, Pages 394-407

  Kocalis, Heidi E ^a,d   Hagan, Scott L ^a   George, Leena ^a   Turney, Maxine K ^a   Siuta, Michael A ^a   Laryea, Gloria N ^a   Morris, Lindsey C ^a   Muglia, Louis J ^c   Printz, Richard L ^a   Stanwood, Gregg D ^a   Niswender, Kevin D ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

AgRP neurons; CNS insulin; Energy balance; Food intake; MTORC2; Obesity; POMC neurons; Rictor

Indexed keywords

AGOUTI RELATED PROTEIN; CRE LOXP RECOMBINASE; HYPOTHALAMIC OREXIGENIC NEUROPEPTIDE; LEPTIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; NEUROPEPTIDE; PROOPIOMELANOCORTIN; PROTEIN KINASE B; PROTEIN KINASE C ALPHA; RAPAMYCIN INSENSITIVE COMPANION OF TOR; RECOMBINASE; SERINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CALORIC INTAKE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DIABETES MELLITUS; ENERGY EXPENDITURE; ENERGY METABOLISM; ENERGY TRANSFER; ENZYME PHOSPHORYLATION; FAT MASS; FOOD INTAKE; GLUCODYNAMICS; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HORMONE BLOOD LEVEL; HORMONE SENSITIVITY; HYDROPHOBICITY; HYPERPHAGIA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIPID DIET; LUNG GAS EXCHANGE; METABOLITE; MOUSE; NERVE CELL; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WEIGHT GAIN;

MUS;

EID: 84902329648     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2014.01.014     Document Type: Article

References (85)

1. Weber J.D., Gutmann D.H. Deconvoluting mTOR biology. Cell Cycle 2012, 11:236-248.
2. Sengupta S., Peterson T.R., Sabatini D.M. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Molecular Cell 2010, 40:310-322.
3. Oh W.J., Jacinto E. mTOR complex 2 signaling and functions. Cell Cycle 2011, 10:2305-2316.
4. Bae S.S., Cho H., Mu J., Birnbaum M.J. Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. Journal of Biological Chemistry 2003, 278:49530-49536.
5. Kumar A., Harris T.E., Keller S.R., Choi K.M., Magnuson M.A., et al. Muscle-specific deletion of rictor impairs insulin-stimulated glucose transport and enhances Basal glycogen synthase activity. Molecular and Cellular Biology 2008, 28:61-70.
6. Bruning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., et al. Role of brain insulin receptor in control of body weight and reproduction. Science 2000, 289:2122-2125.
7. Obici S., Zhang B.B., Karkanias G., Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nature Medicine 2002, 8:1376-1382.
8. Niswender K.D., Morrison C.D., Clegg D.J., Olson R., Baskin D.G., et al. Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes 2003, 52:227-231.
9. Koch L., Wunderlich F.T., Seibler J., Konner A.C., Hampel B., et al. Central insulin action regulates peripheral glucose and fat metabolism in mice. Journal of Clinical Investigation 2008, 118:2132-2147.
10. Heymsfield S.B., Greenberg A.S., Fujioka K., Dixon R.M., Kushner R., et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. Journal of the American Medical Association 1999, 282:1568-1575.
11. Cheng A., Uetani N., Simoncic P.D., Chaubey V.P., Lee-Loy A., et al. Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Developmental Cell 2002, 2:497-503.
12. Munzberg H., Flier J.S., Bjorbaek C. Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 2004, 145:4880-4889.
13. Schwartz M.W., Woods S.C., Porte D., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature 2000, 404:661-671.
14. Schwartz M.W., Erickson J.C., Baskin D.G., Palmiter R.D. Effect of fasting and leptin deficiency on hypothalamic neuropeptide Y gene transcription invivo revealed by expression of a lacZ reporter gene. Endocrinology 1998, 139:2629-2635.
15. Hahn T.M., Breininger J.F., Baskin D.G., Schwartz M.W. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nature Neuroscience 1998, 1:271-272.
16. Xu A.W., Kaelin C.B., Takeda K., Akira S., Schwartz M.W., et al. PI3K integrates the action of insulin and leptin on hypothalamic neurons. Journal of Clinical Investigation 2005, 115:951-958.
17. Morton G.J., Gelling R.W., Niswender K.D., Morrison C.D., Rhodes C.J., et al. Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypothalamic neurons. Cell Metabolism 2005, 2:411-420.
18. Berthoud H.R. Multiple neural systems controlling food intake and body weight. Neuroscience & Biobehavioral Reviews 2002, 26:393-428.
19. De Souza C.T., Araujo E.P., Bordin S., Ashimine R., Zollner R.L., et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 2005, 146:4192-4199.
20. Ropelle E.R., Pauli J.R., Prada P., Cintra D.E., Rocha G.Z., et al. Inhibition of hypothalamic Foxo1 expression reduced food intake in diet-induced obesity rats. Journal of Physiology 2009, 587:2341-2351.
21. Clegg D.J., Gotoh K., Kemp C., Wortman M.D., Benoit S.C., et al. Consumption of a high-fat diet induces central insulin resistance independent of adiposity. Physiology and Behavior 2011, 103:10-16.
22. Posey K.A., Clegg D.J., Printz R.L., Byun J., Morton G.J., et al. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. American Journal of Physiology - Endocrinology and Metabolism 2009, 296:E1003-E1012.
23. Choudhury A.I., Heffron H., Smith M.A., Al-Qassab H., Xu A.W., et al. The role of insulin receptor substrate 2 in hypothalamic and beta cell function. Journal of Clinical Investigation 2005, 115:940-950.
24. Sadagurski M., Leshan R.L., Patterson C., Rozzo A., Kuznetsova A., et al. IRS2 signaling in LepR-b neurons suppresses FoxO1 to control energy balance independently of leptin action. Cell Metabolism 2012, 15:703-712.
25. Niswender K.D., Schwartz M.W. Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. Frontiers in Neuroendocrinology 2003, 24:1-10.
26. Plum L., Belgardt B.F., Bruning J.C. Central insulin action in energy and glucose homeostasis. Journal of Clinical Investigation 2006, 116:1761-1766.
27. Niswender K.D., Gallis B., Blevins J.E., Corson M.A., Schwartz M.W., et al. Immunocytochemical detection of phosphatidylinositol 3-kinase activation by insulin and leptin. Journal of Histochemistry and Cytochemistry 2003, 51:275-283.
28. Sarbassov D.D., Ali S.M., Kim D.H., Guertin D.A., Latek R.R., et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Current Biology 2004, 14:1296-1302.
29. Guertin D.A., Stevens D.M., Thoreen C.C., Burds A.A., Kalaany N.Y., et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Developmental Cell 2006, 11:859-871.
30. Kim M.S., Pak Y.K., Jang P.G., Namkoong C., Choi Y.S., et al. Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis. Nature Neuroscience 2006, 9:901-906.
31. Belgardt B.F., Husch A., Rother E., Ernst M.B., Wunderlich F.T., et al. PDK1 deficiency in POMC-expressing cells reveals FOXO1-dependent and -independent pathways in control of energy homeostasis and stress response. Cell Metabolism 2008, 7:291-301.
32. Schwartz M.W., Sipols A.J., Marks J.L., Sanacora G., White J.D., et al. Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology 1992, 130:3608-3616.
33. Bentzinger C.F., Romanino K., Cloetta D., Lin S., Mascarenhas J.B., et al. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metabolism 2008, 8:411-424.
34. Kumar A., Lawrence J.C., Jung D.Y., Ko H.J., Keller S.R., et al. Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism. Diabetes 2010, 59:1397-1406.
35. Gu Y., Lindner J., Kumar A., Yuan W., Magnuson M.A. Rictor/mTORC2 is essential for maintaining a balance between beta-cell proliferation and cell size. Diabetes 2011, 60:827-837.
36. Hagiwara A., Cornu M., Cybulski N., Polak P., Betz C., et al. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metabolism 2012, 15:725-738.
37. Shiota C., Woo J.T., Lindner J., Shelton K.D., Magnuson M.A. Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. Developmental Cell 2006, 11:583-589.
38. Mazei-Robison M.S., Koo J.W., Friedman A.K., Lansink C.S., Robison A.J., et al. Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons. Neuron 2011, 72:977-990.
39. Siuta M.A., Robertson S.D., Kocalis H., Saunders C., Gresch P.J., et al. Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. PLoS Biology 2010, 8:e1000393.
40. Carson R.P., Fu C., Winzenburger P., Ess K.C. Deletion of Rictor in neural progenitor cells reveals contributions of mTORC2 signaling to tuberous sclerosis complex. Human Molecular Genetics 2012.
41. Tronche F., Kellendonk C., Kretz O., Gass P., Anlag K., et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nature Genetics 1999, 23:99-103.
42. Truett G.E., Heeger P., Mynatt R.L., Truett A.A., Walker J.A., et al. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques 2000, 29(52):54.
43. Boyle M.P., Brewer J.A., Funatsu M., Wozniak D.F., Tsien J.Z., et al. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:473-478.
44. Sasaki T., Kim H.J., Kobayashi M., Kitamura Y.I., Yokota-Hashimoto H., et al. Induction of hypothalamic Sirt1 leads to cessation of feeding via agouti-related peptide. Endocrinology 2010, 151:2556-2566.
45. Ikenoue T., Inoki K., Yang Q., Zhou X., Guan K.L. Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO Journal 2008, 27:1919-1931.
46. Kitamura T., Feng Y., Kitamura Y.I., Chua S.C., Xu A.W., et al. Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nature Medicine 2006, 12:534-540.
47. Cao Y., Nakata M., Okamoto S., Takano E., Yada T., et al. PDK1-Foxo1 in agouti-related peptide neurons regulates energy homeostasis by modulating food intake and energy expenditure. PLoS One 2011, 6:e18324.
48. Morrison C.D., Morton G.J., Niswender K.D., Gelling R.W., Schwartz M.W. Leptin inhibits hypothalamic Npy and Agrp gene expression via a mechanism that requires phosphatidylinositol 3-OH-kinase signaling. American Journal of Physiology - Endocrinology and Metabolism 2005, 289:E1051-E1057.
49. Rojas J.M., Stafford J.M., Saadat S., Printz R.L., Beck-Sickinger A.G., et al. Central nervous system neuropeptide Y signaling via the Y1 receptor partially dissociates feeding behavior from lipoprotein metabolism in lean rats. American Journal of Physiology - Endocrinology and Metabolism 2012, 303:E1479-E1488.
50. Stafford J.M., Yu F., Printz R., Hasty A.H., Swift L.L., et al. Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion. Diabetes 2008, 57:1482-1490.
51. Berthoud H.R. Homeostatic and non-homeostatic pathways involved in the control of food intake and energy balance. Obesity (Silver Spring) 2006, 14(Suppl.5):S197-S200.
52. Porte D., Baskin D.G., Schwartz M.W. Leptin and insulin action in the central nervous system. Nutrition Reviews 2002, 60:S20-S29. (discussion S68-S84, S85-S27).
53. Vaisse C., Halaas J.L., Horvath C.M., Darnell J.E., Stoffel M., et al. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nature Genetics 1996, 14:95-97.
54. Bates S.H., Stearns W.H., Dundon T.A., Schubert M., Tso A.W., et al. STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 2003, 421:856-859.
55. Mirshamsi S., Laidlaw H.A., Ning K., Anderson E., Burgess L.A., et al. Leptin and insulin stimulation of signalling pathways in arcuate nucleus neurones: PI3K dependent actin reorganization and KATP channel activation. BMC Neuroscience 2004, 5:54.
56. Sarbassov D.D., Guertin D.A., Ali S.M., Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005, 307:1098-1101.
57. Jacinto E., Facchinetti V., Liu D., Soto N., Wei S., et al. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 2006, 127:125-137.
58. Garcia-Martinez J.M., Alessi D.R. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochemical Journal 2008, 416:375-385.
59. Yan L., Mieulet V., Lamb R.F. mTORC2 is the hydrophobic motif kinase for SGK1. Biochemical Journal 2008, 416:e19-e21.
60. Urbanska M., Gozdz A., Swiech L.J., Jaworski J. Mammalian target of rapamycin complex 1 (mTORC1) and 2 (mTORC2) control the dendritic arbor morphology of hippocampal neurons. Journal of Biological Chemistry 2012, 287:30240-30256.
61. Thomanetz V., Angliker N., Cloetta D., Lustenberger R.M., Schweighauser M., et al. Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology. Journal of Cell Biology 2013, 201:293-308.
62. Huang W., Zhu P.J., Zhang S., Zhou H., Stoica L., et al. mTORC2 controls actin polymerization required for consolidation of long-term memory. Nature Neuroscience 2013.
63. Bartness T.J., Shrestha Y.B., Vaughan C.H., Schwartz G.J., Song C.K. Sensory and sympathetic nervous system control of white adipose tissue lipolysis. Molecular and Cellular Endocrinology 2010, 318:34-43.
64. Pocai A., Lam T.K., Gutierrez-Juarez R., Obici S., Schwartz G.J., et al. Hypothalamic K(ATP) channels control hepatic glucose production. Nature 2005, 434:1026-1031.
65. Paranjape S.A., Chan O., Zhu W., Horblitt A.M., Grillo C.A., et al. Chronic reduction of insulin receptors in the ventromedial hypothalamus produces glucose intolerance and islet dysfunction in the absence of weight gain. American Journal of Physiology - Endocrinology and Metabolism 2011, 301:E978-E983.
66. Obici S., Feng Z., Karkanias G., Baskin D.G., Rossetti L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nature Neuroscience 2002, 5:566-572.
67. Tiesjema B., la Fleur S.E., Luijendijk M.C., Adan R.A. Sustained NPY overexpression in the PVN results in obesity via temporarily increasing food intake. Obesity 2009, 17:1448-1450.
68. Luo N., Marcelin G., Liu S.M., Schwartz G., Chua S. Neuropeptide Y and agouti-related peptide mediate complementary functions of hyperphagia and reduced energy expenditure in leptin receptor deficiency. Endocrinology 2011, 152:883-889.
69. Sousa-Ferreira L., Garrido M., Nascimento-Ferreira I., Nobrega C., Santos-Carvalho A., et al. Moderate long-term modulation of neuropeptide Y in hypothalamic arcuate nucleus induces energy balance alterations in adult rats. PLoS One 2011, 6:22.
70. van den Hoek A.M., Voshol P.J., Karnekamp B.N., Buijs R.M., Romijn J.A., et al. Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin. Diabetes 2004, 53:2529-2534.
71. Diamant S., Shafrir E. Modulation of the activity of insulin-dependent enzymes of lipogenesis by glucocorticoids. European Journal of Biochemistry 1975, 53:541-546.
72. Winnick J.J., Ramnanan C.J., Saraswathi V., Roop J., Scott M., et al. Effects of 11beta-hydroxysteroid dehydrogenase-1 inhibition on hepatic glycogenolysis and gluconeogenesis. American Journal of Physiology - Endocrinology and Metabolism 2013, 304:12.
73. Rafacho A., Marroqui L., Taboga S.R., Abrantes J.L., Silveira L.R., et al. Glucocorticoids invivo induce both insulin hypersecretion and enhanced glucose sensitivity of stimulus-secretion coupling in isolated rat islets. Endocrinology 2010, 151:85-95.
74. Morgan S.A., Gathercole L.L., Simonet C., Hassan-Smith Z.K., Bujalska I., et al. Regulation of lipid metabolism by glucocorticoids and 11beta-HSD1 in skeletal muscle. Endocrinology 2013, 154:2374-2384.
75. Strack A.M., Bradbury M.J., Dallman M.F. Corticosterone decreases nonshivering thermogenesis and increases lipid storage in brown adipose tissue. American Journal of Physiology 1995, 268:R183-R191.
76. Schakman O., Kalista S., Barbe C., Loumaye A., Thissen J.P. Glucocorticoid-induced skeletal muscle atrophy. International Journal of Biochemistry & Cell Biology 2013, 24:181-187.
77. Laryea G., Schutz G., Muglia L.J. Disrupting hypothalamic glucocorticoid receptors causes HPA axis hyperactivity and excess adiposity. Molecular Endocrinology 2013, 27:1655-1665.
78. Burt M.G., Gibney J., Ho K.K. Characterization of the metabolic phenotypes of Cushing[U+05F3]s syndrome and growth hormone deficiency: a study of body composition and energy metabolism. Clinical Endocrinology 2006, 64:436-443.
79. Konner A.C., Janoschek R., Plum L., Jordan S.D., Rother E., et al. Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. Cell Metabolism 2007, 5:438-449.
80. Geraghty K.M., Chen S., Harthill J.E., Ibrahim A.F., Toth R., et al. Regulation of multisite phosphorylation and 14-3-3 binding of AS160 in response to IGF-1, EGF, PMA and AICAR. Biochemical Journal 2007, 407:231-241.
81. Nobukuni T., Joaquin M., Roccio M., Dann S.G., Kim S.Y., et al. Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:14238-14243.
82. Hill J.W., Williams K.W., Ye C., Luo J., Balthasar N., et al. Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice. Journal of Clinical Investigation 2008, 118:1796-1805.
83. Iskandar K., Cao Y., Hayashi Y., Nakata M., Takano E., et al. PDK-1/FoxO1 pathway in POMC neurons regulates Pomc expression and food intake. American Journal of Physiology - Endocrinology and Metabolism 2010, 298:E787-E798.
84. Lin H.V., Plum L., Ono H., Gutierrez-Juarez R., Shanabrough M., et al. Divergent regulation of energy expenditure and hepatic glucose production by insulin receptor in agouti-related protein and POMC neurons. Diabetes 2010, 59:337-346.
85. Krysiak R., Obuchowicz E., Herman Z.S. Interactions between the neuropeptide Y system and the hypothalamic-pituitary-adrenal axis. European Journal of Endocrinology 1999, 140:130-136.